- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-3-3-mer
- Ligands
- 7 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.3: 9 residues within 4Å:- Chain C: E.239, N.240
- Chain E: G.27, Y.28, R.62, W.63, G.64, Y.67, Y.87
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:Y.28
- Hydrogen bonds: E:R.62, E:R.62
NAG-NAG-BMA-MAN-MAN-MAN-MAN.7: 8 residues within 4Å:- Chain G: E.239, N.240
- Chain I: G.27, Y.28, R.62, W.63, G.64
- Ligands: NAG.42
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:R.62, I:R.62
NAG-NAG-BMA-MAN-MAN-MAN-MAN.12: 8 residues within 4Å:- Chain K: E.239, N.240
- Chain M: G.27, Y.28, R.62, W.63, G.64
- Ligands: NAG.53
4 PLIP interactions:4 interactions with chain M- Hydrophobic interactions: M:Y.28
- Hydrogen bonds: M:G.27, M:R.62, M:R.62
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 54 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 3 residues within 4Å:- Chain C: N.194, T.196, N.204
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain C: N.193, N.205
Ligand excluded by PLIPNAG.15: 5 residues within 4Å:- Chain C: N.265, I.286, G.399, N.400
- Ligands: NAG.19
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain C: N.317
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain C: I.321, N.323, T.425, R.427
- Ligands: NAG.22
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain C: N.347, S.349
Ligand excluded by PLIPNAG.19: 5 residues within 4Å:- Chain C: P.263, N.265, R.290, N.400
- Ligands: NAG.15
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain C: L.229, S.255, K.404, N.406
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain C: W.3, N.460
- Chain F: N.97
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain C: N.354
- Ligands: NAG.17
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain C: N.161, T.162
- Chain D: S.75, W.76
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: N.93
- Chain C: N.98, E.154
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain C: K.103, N.117, L.136, G.283, D.284
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain C: N.198, T.200, S.238, L.241
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain C: E.55, N.56
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain E: T.20, T.22, N.68
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain F: N.101, S.103
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain F: R.123, N.127
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: R.53
- Chain G: N.98, E.154
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain G: K.103, N.117, R.132, Y.134, D.284
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain G: N.194, N.204
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain G: N.205
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain G: N.265, G.399, N.400
- Ligands: NAG.37
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain G: I.321, N.323, K.423
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain G: P.263, N.400
- Ligands: NAG.35
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain G: K.216, S.255, N.406
- Ligands: NAG-NAG-BMA.8
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain G: N.354, T.356
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain G: R.156, N.161, T.162
- Chain H: W.76
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain G: E.55, N.56
- Chain J: S.18
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain G: N.198, T.200, I.236, H.315
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.7
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain G: W.3, E.458, C.459, N.460
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain G: N.419, S.421
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain G: R.313, N.317
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain G: N.347
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain I: T.20, T.22, E.66, N.68
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain J: E.124, N.127
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain J: N.101, S.103, W.104
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain B: N.54
- Chain K: N.98
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain K: K.103, N.117, S.119, Y.134
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain K: N.194, K.195, N.204
Ligand excluded by PLIPNAG.53: 6 residues within 4Å:- Chain K: N.198, G.199, T.200, S.238, L.241
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.12
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain K: N.193, N.205
Ligand excluded by PLIPNAG.55: 5 residues within 4Å:- Chain K: N.265, I.286, G.399, N.400
- Ligands: NAG.58
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain K: N.323
- Chain L: R.62
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain K: T.334, N.347
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain K: N.400, T.402
- Ligands: NAG.55
Ligand excluded by PLIPNAG.59: 5 residues within 4Å:- Chain K: K.216, N.226, S.255, N.406
- Ligands: NAG-NAG.9
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain K: N.354, T.356
Ligand excluded by PLIPNAG.61: 7 residues within 4Å:- Chain K: R.156, N.161, T.162
- Chain L: H.73, A.74, S.75, W.76
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain K: W.3, N.460
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain K: E.55, N.56
- Chain N: S.18
Ligand excluded by PLIPNAG.64: 5 residues within 4Å:- Chain M: T.22, R.61, W.63, E.66, N.68
Ligand excluded by PLIPNAG.65: 2 residues within 4Å:- Chain N: N.101, S.103
Ligand excluded by PLIPNAG.66: 2 residues within 4Å:- Chain N: N.127, Y.128
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, M. et al., Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces. Nat Commun (2021)
- Release Date
- 2021-08-18
- Peptides
- 2909 Light Chain: A
2909 Heavy Chain: B
Envelope glycoprotein gp120: CGK
3BNC117 Heavy Chain: DHL
3BNC117 Light Chain: EIM
Envelope glycoprotein gp41: FJN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LB
HC
GG
DK
KD
BH
EL
AE
CI
IM
MF
FJ
JN
N
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-3-3-mer
- Ligands
- 7 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 54 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, M. et al., Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces. Nat Commun (2021)
- Release Date
- 2021-08-18
- Peptides
- 2909 Light Chain: A
2909 Heavy Chain: B
Envelope glycoprotein gp120: CGK
3BNC117 Heavy Chain: DHL
3BNC117 Light Chain: EIM
Envelope glycoprotein gp41: FJN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LB
HC
GG
DK
KD
BH
EL
AE
CI
IM
MF
FJ
JN
N